Malaria prophylaxis with proguanil in children living in a malaria-endemic area

N Limsomwong1, L W Pang, P Singharaj

  • 1U.S. Army Medical Component, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.

Insights

Daily proguanil and weekly chloroquine showed similar efficacy for malaria prevention in children. Proguanil had more vivax malaria failures, but both treatments were well-tolerated.

Area of Science:

  • Tropical Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • Malaria remains a significant public health concern in endemic regions.
  • Effective malaria prophylaxis is crucial for protecting vulnerable populations, especially children.
  • Evaluating different antimalarial drug regimens is essential for optimizing prevention strategies.

Purpose of the Study:

  • To compare the efficacy and safety of daily proguanil versus weekly chloroquine for malaria prophylaxis in children.
  • To assess the prophylactic effects against Plasmodium falciparum and Plasmodium vivax malaria.
  • To determine the incidence of malaria infections and treatment-related side effects in both groups.

Main Methods:

  • A randomized controlled trial involving 170 children aged 5-10 years in a malaria-endemic area.
  • Children were matched and randomly assigned to receive either daily proguanil or weekly chloroquine.
  • Weekly malaria smears and monitoring for side effects were conducted throughout the study period.

Main Results:

  • No statistically significant difference in Plasmodium falciparum malaria prophylaxis between daily proguanil and weekly chloroquine.
  • Proguanil showed potential causal prophylactic effects against Plasmodium falciparum.
  • Significantly higher rates of Plasmodium vivax prophylactic failures were observed in the proguanil group (P < 0.01).
  • Adverse events were infrequent, mild, and comparable between the two treatment groups.

Conclusions:

  • Both daily proguanil and weekly chloroquine demonstrate comparable efficacy for Plasmodium falciparum malaria prophylaxis.
  • Daily proguanil may offer some causal prophylactic benefit against Plasmodium falciparum.
  • Weekly chloroquine appears more effective in preventing Plasmodium vivax malaria breakthrough infections.
  • Both regimens are generally well-tolerated in pediatric populations.

Related Concept Videos

Symbiosis00:58

Symbiosis

Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...